© 2003 by European Society of Cardiology
Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope
Cardiac Arrhythmia Center, Department of Medicine (Cardiovascular Division), University of Minnesota Medical School Minneapolis, Minnesota, U.S.A.
AIM: Changes in circulating catecholamine concentrations during vasovagal faints have been the subject of considerable study. However, whether catecholamines are part of the triggering mechanism, or principally reflect attempted compensation for an evolving circulatory crisis is unknown. To address this issue, we determined whether the circulating catecholamine response to upright posture differs among patients with and without inducible vasovagal faints at a time when there is no detectable haemodynamic compromise.
METHODS AND RESULTS: Blood samples for measurement of adrenaline and noradrenaline (Norepi) concentrations were obtained in the baseline state, and at both 2–3 min and 4–6 min of upright posture in 22 patients undergoing head-up tilt-table testing for evaluation of syncope of unknown cause. In 11 individuals tilt-testing induced syncope at >5 min head-up posture (Group 1). In 11 other individuals tilt testing did not result in syncope (Group 2). Supine arterial catecholamine levels were comparable in the two groups. However, adrenaline concentratrions during upright posture tended to be greater at 2–3 min and were significantly greater at 4–6 min in Group 1 than in Group 2 (P<0.01). These differences occurred in the absence of significant intergroup differences in mean arterial pressure or cardiac cycle lengths. Norepi concentrations also increased in both groups, but without significant differences.
CONCLUSION: Circulating adrenaline concentrations in posturally induced vasovagal faints rise more rapidly in vasovagal fainters than in comparably posturally stressed non-fainters, and were significantly greater in fainters prior to either detectable haemodynamic compromise or diminution of circulating Norepi levels. These findings suggest that a premonitory rise in adrenaline concentrations occurs in vasovagal fainters unassociated with an evolving circulatory crisis.
Key Words: Vasovagal syncope, tilt-table testing, catecholamines
Correspondence: David G. Benditt, MD, MMC 508, 420 Delaware St SE, Minneapolis, Minnesota 55455. Tel.: (612) 625-4401; Fax: (612) 624-4937; E-mail: bendi001{at}umn.edu
[1] Chosy JJ and Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res 1965; 9: 189–194.[CrossRef][Web of Science][Medline]
[2] Goldstein DS, Spanarkel M, Pitterman A, Toltzis R, Gratz E, Epstein S, Keiser HR. Circulatory control mechanisms in vasodepressor syncope. Am Heart J 1982; 104: 1071–1075.[CrossRef][Web of Science][Medline]
[3] Vingerhoets AJJM. Biochemical changes in two subjects succumbing to syncope. Psychosom Med 1984; 46: 95–103.
[4] Sander-Jensen K, Secher NH, Astrup A, Christensen NJ, Giese J, Schwartz TW, Warbnerg J, Bie P. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol 251 (Regulatory Integrative Comp Physiol) 1986; 20: R742–R748.
[5] Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle L. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol 1988; 11: 1202–1214.[CrossRef][Medline]
[6] Fitzpatrick A, Williams T, Ahmed R, Lightman S, Bloom SR, Sutton R. Echocardiographic and endocrine changes during vasovagal syncope inbduced by prologed head-up tilt. Eur J Cardiac Pacing Electrophys 1992; 2: 121–128.
[7] Sra JS, Murthy V, Natale A, Jazayeri MR, Dhala A, Deshpande S, Sheth M, Akhtar M. Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. Am J Cardiol 1994; 73: 33–37.[CrossRef][Web of Science][Medline]
[8] Klingenheben T, Kalusche D, Li Y-G, Schøpperl M, Hohnloser SH. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with ß receptor antagonists. J Cardiovasc Electrophysiol 1996; 7: 802–808.[Web of Science][Medline]
[9] Jardine DL, Melton I, Crozier IG, Bennett SI, Donald RA, Ikram H. Neurohumoral response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 1997; 79: 1302–1306.[CrossRef][Web of Science][Medline]
[10] Almquist A, Goldenberg IF, Milstein S, Chen M-Y, Chen X, Hansen R, Gornick CC, Benditt DG. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. New Engl J Med 1989; 320: 346–351.[Abstract]
[11] Benditt DG, Ferguson DW, Grubb BP. Tilttable testing for assessing syncope. An American College of Cardiology expert consensus document. J Am Coll Cardiol 1996; 28: 263–275.[CrossRef][Web of Science][Medline]
[12] Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thompson PE, van Dijk G, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001; 22: 1256–1306.
[13] Van Lieshout JJ, Wieling W, Karemaker JM, Eckberg DL. The vasovagal response. Clin Sci 1991; 81: 575–586.[Medline]
[14] Quan KJ, Carlson MD, Thames MC. Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope. Pacing Clin Electrophysiol 1997; 20:Pt.II 764–774.[CrossRef][Medline]
[15] Morillo CA, Klein GJ, Jones DL, Yee R. Time and frequency domain analysis of heart rate variability during orthostatic stress in patients with neurally-mediated syncope. Am J Cardiol 1994; 74: 1258–1262.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Alboni, M. Brignole, and E. C. degli Uberti Is vasovagal syncope a disease? Europace, February 1, 2007; 9(2): 83 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schroeder, A. L. Birkenfeld, A. F. Mayer, J. Tank, A. Diedrich, F. C. Luft, and J. Jordan Norepinephrine Transporter Inhibition Prevents Tilt-Induced Pre-Syncope J. Am. Coll. Cardiol., August 1, 2006; 48(3): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||